Alliance for Clinical Trials in Oncology – Trials Studying Thyroid Cancer 

  • Alliance A091302: “Randomized Phase II Study of Sorafenib With or Without Everolimus in Patients with Radioactive Iodine Refractory Hürthle Cell Thyroid Cancer” | Study Chair Dr. Eric Sherman

Find the At-A-Glance Sheet HERE 

  • Alliance A091305: “Phase 2 Randomized Study Of Efatutazone, An Oral PPAR Agonist, In Combination With Paclitaxel Versus Paclitaxel In Patients With Advanced Anaplastic Thyroid Cancer” | Study Chair Dr. Robert Smallridge

Find the At-A-Glance Sheet HERE